Search





Search





Markets
/
Stocks
/
nasdaq-coag
/

Hemab Therapeutics Holdings Ord Shs (Proposed)

COAG

Add to Watchlist

32.370USD

+4.650+16.77%

Close 06/26, 16:00（ET）Quotes delayed by 15 min

1.43BMarket Cap

--P/E TTM

Hemab Therapeutics Holdings Ord Shs (Proposed)

32.370

+4.650+16.77%

Earnings Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Earnings Income Statement Balance Sheet Cash Flow Statement

You can find the annual or quarterly income statement of Hemab Therapeutics Holdings Ord Shs (Proposed) here for insights into the performance and operational efficiency of Hemab Therapeutics Holdings Ord Shs (Proposed).

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

Operating expenses

--23.61M

R&D expenses

--19.46M

Depreciation, depletion, and amortization

--73.00K

Operating profit

---23.61M

Net non-operating interest income (expenses)

Non-operating interest income

--1.22M

Other non-operating income (expenses)

---282.00K

Income before tax

---22.68M

Income tax

--12.00K

Income after tax

---22.69M

Net income from continuous operations

---22.69M

Net income attributable to controlling interests

---22.69M

Net income attributable to common shareholders

---22.69M

Basic earnings per share

---0.51

Diluted earnings per share

---0.51

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

